ARCHIVES

States Sue Bristol-Myers Alleging Firm Took Illegal Actions To Block Taxol Competitors

This article is from The Cancer Letter archive.

Vol. 28 No. 23 | June 7, 2002

Download PDF Visit The Full Archive

Related Articles

Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials.

October 15, 2004

Aventis, MediGene In Pact For Development Of Vaccine.

February 25, 2000

NCCS Networker Volume 9 Issue 1, Spring 1995

April 13, 1995

ACS, In Reorganization, To Emphasize Funds for Young Scientists

January 12, 1996

SWOG Trial Reports Longest Survival To Date For NSCLC

June 29, 2001

Afatinib Delays Tumor Growth In LUX-Head and Neck 1 Study

October 31, 2014